东方证券保荐承销有限公司 关于百合花集团股份有限公司 向特定对象发行股票会后事项承诺函 中国证券监督管理委员会、上海证券交易所： 百合花集团股份有限公司（以下简称"公司"、"发行人"、"百合花"）向特 定对象发行股票（以下简称"本次发行"）的申请已于 2023 年 8 月 25 日经上海 证券交易所主板上市审核中心（以下简称"上交所上市审核中心"）审核通过。 东方证券承销保荐有限公司（以下简称"东方投行"、"保荐人"）作为发行人本 次向特定对象发行股票的保荐人和主承销商，根据中国证券监督管理委员会和上 海证券交易所的会后事项监管要求及《上海证券交易所上市公司证券发行上市审 核规则》，对发行人自上交所上市审核中心审核通过之日至本承诺函签署日期间 的会后事项进行了审慎核查，具体如下： 一、发行人经营业绩变化情况及说明 （一）发行人 2023 年 1-6 月人经营业绩变化情况及主要原因 2023 年 1-6 月，公司主要财务数据情况如下： 单位：万元 | 项目 | 2023 年 | 2022 年 | 1-6 月 | 2022 | 年度 | | --- | --- | --- | --- | --- | --- | ...

证券代码：603823 证券简称：百合花 公告编号：2023-057 百合花集团股份有限公司 关于控股股东部分股份质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 1 百合花集团股份有限公司（以下简称"公司"）控股股东百合花控股有限公 司（以下简称"百合花控股"）持有公司股份 263,941,361 股，占公司总股本 的 64.04%，本次质押后，百合花控股累计质押公司股份 62,581,615 股，占其 持有公司股份总数的 23.71%，占公司总股本的 15.18%。该事项不涉及关联交 易，不构成重大资产重组的情形。 一、上市公司股份质押 公司于2023年9月6日接到控股股东百合花控股通知，获悉控股股东百合花控 股将其持有的本公司21,960,000股无限售条件流通股质押给上海浦东发展银行股份 有限公司杭州德胜支行（以下简称"浦发银行"）、中信银行股份有限公司杭州 萧山支行（以下简称"中信银行"）和北京银行股份有限公司杭州分行（以下简 称"北京银行"），具体事项如下： | | | | 是否为 ...

Financial Performance - The company's operating revenue for the first half of 2023 was CNY 1,131,403,097.94, a decrease of 18.43% compared to CNY 1,387,108,064.77 in the same period last year[22]. - The net profit attributable to shareholders for the first half of 2023 was CNY 54,897,701.46, down 63.11% from CNY 148,807,892.89 in the previous year[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 46,197,748.37, a decline of 66.86% compared to CNY 139,383,632.05 in the same period last year[22]. - The net cash flow from operating activities for the first half of 2023 was CNY 52,306,288.66, compared to a negative cash flow of CNY 7,438,277.17 in the same period last year[22]. - The total assets at the end of the reporting period were CNY 3,368,207,931.42, a decrease of 4.22% from CNY 3,516,519,091.92 at the end of the previous year[22]. - The net assets attributable to shareholders at the end of the reporting period were CNY 2,140,325,101.61, down 0.49% from CNY 2,150,911,724.95 at the end of the previous year[22]. - Basic earnings per share for the first half of 2023 were CNY 0.13, a decrease of 72.34% from CNY 0.47 in the same period last year[24]. - The weighted average return on net assets for the first half of 2023 was 2.52%, a decrease of 4.63 percentage points from 7.15% in the previous year[24]. - The company attributed the decline in financial indicators to overall weak domestic and international market demand, leading to oversupply and a decrease in both sales and prices[24]. Operational Highlights - The company operates more than 50 production lines, positioning itself as a leading player in the domestic organic pigment industry[37]. - The company has established a centralized procurement system for key raw materials, enhancing operational efficiency[33]. - The company utilizes a production model based on sales forecasts, ensuring alignment with market demand[33]. - The company employs a sales model that includes both direct sales and distribution, tailored to the needs of different customer segments[34]. - The company has a comprehensive range of organic pigment products, covering over 200 specifications across various applications[37]. - The company’s organic pigments are primarily used in inks, coatings, and plastics, with applications expanding into automotive, construction, and cosmetics[36]. Research and Development - The company has obtained 54 authorized invention patents and 21 utility model patents, demonstrating strong R&D capabilities[38]. - The company’s R&D expenses were CNY 41,126,702.16, a decrease of 6.96% compared to the previous year[46]. - Research and development investments have increased by 25%, focusing on innovative technologies and product enhancements[113]. - The company aims to enhance its research and development efforts to innovate and improve product offerings in the upcoming quarters[173]. Environmental Commitment - The company is committed to environmental protection, ensuring that all pollutants meet the discharge standards, with a total wastewater discharge of 312.398 million tons per year[75]. - The company generated 120 tons of general solid waste and 3,838.042 tons of hazardous waste in the first half of 2023, with all hazardous waste properly disposed of by a qualified third party[76]. - The company has established a wastewater treatment process that includes regulation, sedimentation, A/O, and activated carbon filtration[87]. - The company’s air pollution control measures include deep cooling and activated carbon adsorption, ensuring compliance with emission standards[89]. Future Outlook - The company provided a positive outlook for the second half of 2023, projecting a revenue growth of 10% to 15%[113]. - New product launches are expected to contribute an additional 200 million yuan in revenue by the end of 2023[113]. - The company plans to enhance its digital marketing strategies, allocating an additional 50 million yuan to improve online engagement and sales[113]. - The management emphasized the importance of sustainable practices in operations, aiming for a 10% reduction in carbon emissions by 2025[113]. Shareholder Information - The largest shareholder, Baihehua Holdings Co., Ltd., holds 263,941,361 shares, accounting for 64.04% of total shares, with 226,719,746 shares pledged[136]. - The company has not proposed any profit distribution or capital reserve fund transfer plans for the first half of 2023[70]. - The total number of shares after the recent capital increase is 412,160,476, with a cash dividend of RMB 0.21 per share distributed to shareholders[130]. - The company has committed to maintaining a dividend payout ratio of at least 30% of net profits for the fiscal year[113]. Financial Strategy - The company is actively pursuing capital market financing, having responded to inquiries from the Shanghai Stock Exchange regarding a specific stock issuance[44]. - The company has committed to ensuring that any future equity incentive policies are linked to the execution of measures to compensate for dilution of immediate returns[119]. - The company’s financial strategy includes a focus on enhancing shareholder value through profit distribution and capital management[178]. - The company is focusing on maintaining a strong capital structure while exploring opportunities for market expansion and new product development[182].

证券代码：603823 证券简称：百合花 公告编号：2023-052 百合花集团股份有限公司 关于收到上海证券交易所关于向特定对象发行股票的 审核中心意见落实函的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 2023年8月25日，百合花集团股份有限公司（以下简称"公司"）收到上海 证券交易所（以下简称"上交所"）出具的《关于百合花集团股份有限公司向特 定对象发行股票的审核中心意见落实函》（上证上审（再融资）〔 2023 〕642 号 ）（以下简称"《落实函》"）。上交所对公司提交的向特定对象发行股票 （以下简称"本次发行"）申请文件进行了审核，审核中心会议讨论形成问题并 由公司予以落实，具体需落实问题为： "请发行人结合 2023 年 1-6 月份公司业绩情况、行业发展情况、市场供需变 化等因素分析公司业绩变化的原因，说明是否存在业绩持续下滑的风险，并针对 性提示相应风险。 请保荐机构及申报会计师核查并发表明确意见。" 公司将与本次发行相关中介机构按照上述《落实函》的要求，在规定期限内 将有关材料报送至上交所受理 ...

上海证券交易所文件 请你公司对上述问题逐项落实并及时提交回复，若回复涉及 对募集说明书的修改，请以楷体加粗标明。 ─────────────── 上证上审（再融资）〔2023〕624 号 关于百合花集团股份有限公司 向特定对象发行股票的审核中心意见落实函 百合花集团股份有限公司、东方证券承销保荐有限公司： 根据《证券法》《上市公司证券发行注册管理办法》《上海 证券交易所上市公司证券发行上市审核规则》等有关规定，本所 对百合花集团股份有限公司向特定对象发行股票申请文件进行 了审核，审核中心会议讨论形成如下问题，请予落实： 请发行人结合 2023 年 1-6 月份公司业绩情况、行业发展情 况、市场供需变化等因素分析公司业绩变化的原因，说明是否存 在业绩持续下滑的风险，并针对性提示相应风险。 请保荐机构及申报会计师核查并发表明确意见。 上海证券交易所 二〇二三年八月二十五日 主题词：主板 再融资 落实意见函 上海证券交易所 2023 年 08 月 25 日印发 ...

关于百合花集团股份有限公司向特定对象 发行股票审核意见的通知 百合花集团股份有限公司、东方证券承销保荐有限公司： 根据《证券法》《上市公司证券发行注册管理办法》《上 海证券交易所上市公司证券发行上市审核规则》等有关法律、 法规及本所有关规定，上海证券交易所上市审核中心召开审 核会议对百合花集团股份有限公司向特定对象发行股票的 申请文件进行了审核，形成如下审核意见： 一、审核意见 百合花集团股份有限公司向特定对象发行股票申请符 合发行条件、上市条件和信息披露要求。 二、落实问题 请发行人结合 2023 年 1-6 月份公司业绩情况、行业发展 情况、市场供需变化等因素分析公司业绩变化的原因，说明 是否存在业绩持续下滑的风险，并针对性提示相应风险。 请保荐机构及申报会计师核查并发表明确意见。 请你公司对上述问题逐项落实并及时提交回复，本所将 在履行相关程序并收到你公司申请文件后提交中国证监会 注册。 请你公司按照相关规定，及时履行临时公告义务。 上海证券交易所上市审核中心 2023 年 8 月 25 日 ...

证券代码：603823 证券简称：百合花 公告编号：2023-051 百合花集团股份有限公司 关于向特定对象发行股票申请获得上海证券交易所 审核通过的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 2023年8月25日，百合花集团股份有限公司（以下简称"公司"）收到上海 证券交易所（以下简称"上交所"）出具的《关于百合花集团股份有限公司向特 定对象发行股票审核意见的通知》（以下简称"《通知》"）。《通知》主要内 容如下： 一、审核意见 百合花集团股份有限公司向特定对象发行股票申请符合发行条件、上市条件 和信息披露要求。 二、落实问题 请保荐机构及申报会计师核查并发表明确意见。 公司本次向特定对象发行股票事项尚需公司针对《通知》中提出的问题进行 落实并及时回复，上交所将在收到公司落实意见回复后提交中国证券监督管理委 员会（以下简称"中国证监会"）注册。公司本次向特定对象发行股票事项尚需 获得中国证监会同意注册后方可实施，最终能否获得中国证监会同意注册的决定 1 及其时间尚存在不确定性。公司将根据上述事项进展情况，严格 ...

百合花集团股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 百合花集团股份有限公司（以下简称"公司"或"百合花"）于2023年5 月22日召开百合花2022年年度股东大会，审议通过了《关于变更公司注册资本 及修订<公司章程>的议案》。变更的具体内容详见公司于2023年4月20日上海 证券交易所网站披露的《关于变更注册资本及修订<公司章程>的公告》（ 2023-025）。 近日，公司取得了浙江省市场监督管理局换发的《营业执照》，完成了工 商变更登记及公司章程备案的手续，变更后的《营业执照》登记的相关信息如 下： 名称：百合花集团股份有限公司 股票代码：603823 股票简称：百合花 公告编号：2023-050 特此公告。 1 百合花集团股份有限公司董事会 2023年8月15日 统一社会信用代码证：9133010025569303X1 类型：其他股份有限公司（上市） 住所：浙江省杭州市钱塘新区经五路1768号 法定代表人：陈立荣 注册资本：肆亿壹仟贰佰壹拾陆万零肆佰柒拾陆 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥553,063,716.69, representing a decrease of 14.43% compared to the same period last year[5]. - The net profit attributable to shareholders was ¥15,613,314.50, down 76.61% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥12,973,954.59, a decline of 78.83% compared to the previous year[5]. - The basic earnings per share for the period was ¥0.05, reflecting a decrease of 76.19% year-on-year[5]. - Total operating revenue for Q1 2023 was CNY 646,323,104.51, an increase of 16.9% compared to CNY 553,063,716.69 in Q1 2022[18]. - Net profit for Q1 2023 reached CNY 68,121,954.34, a significant increase of 321.5% from CNY 16,164,151.02 in Q1 2022[19]. - Earnings per share for Q1 2023 were CNY 0.21, compared to CNY 0.05 in Q1 2022, marking a 320% increase[20]. - The total profit for Q1 2023 was ¥23.54 million, down 66.5% from ¥70.07 million in Q1 2022[29]. Cash Flow and Assets - The net cash flow from operating activities was -¥1,145,210.76, indicating a significant cash outflow[5]. - Cash flow from operating activities in Q1 2023 was CNY 278,422,306.49, down 17.4% from CNY 337,041,351.45 in Q1 2022[21]. - The net cash flow from operating activities for Q1 2023 was -1,145,210.76 RMB, compared to -53,925,672.57 RMB in Q1 2022, indicating an improvement[22]. - The total cash and cash equivalents at the end of Q1 2023 stood at 312,312,852.58 RMB, compared to 130,767,685.44 RMB at the end of Q1 2022, showing significant growth[24]. - The company's total assets decreased to 2,661,832,953.28 RMB from 2,724,885,286.17 RMB at the end of 2022[26]. - Current assets totaled 1,408,652,850.45 RMB, down from 1,462,731,554.53 RMB at the end of 2022[25]. Liabilities and Equity - The total liabilities of the company decreased to RMB 1,200,000,000.00, down from RMB 1,300,000,000.00, reflecting a reduction of about 7.69%[15]. - Total liabilities as of Q1 2023 amounted to CNY 1,025,992,812.58, a decrease from CNY 1,121,675,919.85 in the previous year[19]. - The company's total liabilities decreased to 688,484,838.16 RMB from 772,863,423.23 RMB at the end of 2022, reflecting a reduction in debt[26]. - The total equity attributable to shareholders reached CNY 2,167,071,822.07, up from CNY 2,150,911,724.95 in Q1 2022[19]. - The total equity increased to 1,973,348,115.12 RMB from 1,952,021,862.94 RMB at the end of 2022, indicating a positive trend in shareholder value[27]. Market Conditions and Competition - The company attributed the decline in profits to weak market demand and intense industry competition, along with delayed cost transmission from raw material price changes[9]. - Baihehua Group's financial report for Q1 2023 did not include any significant new product launches or technological advancements mentioned in the conference call[13]. Research and Development - Research and development expenses for Q1 2023 were CNY 23,219,505.30, slightly higher than CNY 22,250,565.03 in Q1 2022[19]. - Research and development expenses for Q1 2023 were ¥17.84 million, slightly up from ¥17.32 million in Q1 2022[28].

Financial Performance - The company's operating revenue for 2022 was CNY 2,468,044,923.76, representing a 0.44% increase compared to CNY 2,457,295,597.04 in 2021[24]. - The net profit attributable to shareholders for 2022 was CNY 214,500,348.12, a decrease of 31.22% from CNY 311,873,329.41 in 2021[24]. - The net cash flow from operating activities was CNY 164,688,992.27, down 27.47% from CNY 227,061,522.67 in the previous year[24]. - The total assets at the end of 2022 were CNY 3,516,519,091.92, an increase of 1.51% from CNY 3,464,294,671.59 at the end of 2021[25]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 198,792,579.57, a decrease of 32.45% from CNY 294,273,605.95 in 2021[24]. - The company's total equity attributable to shareholders at the end of 2022 was CNY 2,150,911,724.95, reflecting a 6.40% increase from CNY 2,021,444,840.15 in 2021[24]. - Basic earnings per share decreased by 32.32% to CNY 0.67 compared to CNY 0.99 in 2021[26]. - The company's R&D expenses amounted to CNY 94,801,035.25, which is a 0.45% increase compared to the previous year, indicating ongoing investment in innovation[60]. - The average gross profit margin for pigments was 19.97%, reflecting a decrease of 1.59% compared to the previous year[119]. Investment and Capital Structure - The company plans to distribute a cash dividend of CNY 2.10 per 10 shares, totaling approximately CNY 66,768,492 to shareholders[6]. - The company will increase its share capital by 3.0 shares for every 10 shares held, resulting in a total of 95,383,560 new shares issued[6]. - The company plans to raise CNY 1.178 billion to invest in lithium iron phosphate and battery-grade lithium carbonate projects, among others, to enhance its dual business structure of chemical materials and new energy materials[36]. - The company plans to raise CNY 1.178 billion to invest in projects including 40,000 tons of lithium iron phosphate and 3,000 tons of battery-grade lithium carbonate, aiming for a strategic shift towards new energy materials[70]. - The company plans to invest CNY 390 million to establish a new production line with an annual capacity of 5,000 tons of high-performance organic pigments, expected to be completed by 2024[111]. Operational Challenges and Strategies - The company faced challenges such as intense industry competition and rising raw material and energy costs, leading to a decline in gross profit margin[26]. - The company is actively optimizing its operational strategies to maintain market share amid a complex business environment[34]. - The company’s sodium production capacity did not meet expectations, contributing to the decline in net profit[26]. - The company is exploring strategic partnerships to enhance its product offerings and market share in the pigment industry[139]. - The company is committed to developing high-performance organic pigments to meet increasing safety and environmental standards in the market[130]. Research and Development - The company has obtained 54 authorized invention patents and 21 utility model patents, showcasing its strong R&D capabilities[52]. - The company is focusing on the development of new energy materials, achieving success in solving technical challenges related to sodium-ion cathode materials[39]. - The company has established a national-level enterprise technology center and holds 54 authorized invention patents, with 10 more pending, and has set 17 industry standards[132]. - The company employed 203 R&D personnel, representing 11.14% of the total workforce[73]. Environmental and Safety Measures - The company emphasizes safety and environmental protection, continuously improving safety production management levels[38]. - The company has implemented high-standard environmental protection measures, including RTO engineering and anaerobic waste gas treatment[54]. - The company has invested 82.6352 million yuan in environmental protection during the reporting period[190]. - The total wastewater discharge for 2022 was 2,943,989 tons, with COD emissions of 87.453 tons and ammonia nitrogen emissions of 0.963 tons[191]. - The company has established comprehensive waste treatment facilities to comply with national environmental policies, but potential environmental risks remain, which could increase costs[142]. Market Position and Competitive Advantage - The company is positioned as a leading enterprise in the domestic organic pigment industry, with comprehensive competitive advantages[51]. - The company is a leading player in the domestic organic pigment industry, with a strong competitive edge in production scale, technology level, and product quality[91]. - The global high-performance organic pigment market is expected to grow at a rate of approximately 10% annually, with current production accounting for 15-20% but sales revenue reaching 40-50%[130]. - The company has established a comprehensive sales network and a stable customer base, which are critical for maintaining competitive advantages in the organic pigment market[83]. Governance and Management - The company has a structured approach to governance, ensuring compliance with regulatory requirements[162]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with legal requirements[148]. - The company has established a compensation committee to review and approve remuneration policies for its executives[161]. - The company’s financial management is overseen by a qualified team with extensive experience in finance and accounting[159]. - The company actively engages with investors through various communication channels, ensuring fair treatment and protection of their rights[151]. Risks and Uncertainties - The company faces significant barriers to entry in the organic pigment industry due to complex production processes and stringent environmental regulations[80]. - The company faces risks from intense market competition, cyclical fluctuations in downstream industries, and volatility in raw material prices[140]. - The company has limited operational experience in the new energy sector, facing uncertainties in policy, market, and technology, which may hinder its performance in this area[143]. - The company has not yet signed agreements with customers for its lithium iron phosphate business, leading to significant market development risks[143].